Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of iodine-131–labeled monoclonal antibody BC8 used before autologous stem cell transplant in relapsed or refractory Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating brentuximab vedotin plus AVD in limited-stage Hodgkin lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating chemotherapy followed by unrelated donor stem cell transplantation for blood and immune system cancers; …
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies [Phase 2]
This Phase 2 randomized trial comparing haplo cord blood transplantation versus double umbilical cord blood transplantation for hematologic …
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic [NA]
This clinical trial update reports on cytokine kinetics and prognostic indicators in Hodgkin lymphoma, with the study status listed as compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Preservation of Ovarian Function After Hematopoietic Cell Transplant [Phase 2]
Phase 2 trial investigating preservation of ovarian function after hematopoietic cell transplantation in patients with hematologic cancers; …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
A completed multi-institutional NIH study evaluated late treatment effects in long-term survivors of Hodgkin lymphoma, investigating long-te…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248) [Phase 1]
Phase 1 dose-escalation study of MK-8776 (SCH 900776) with and without gemcitabine in solid tumors or lymphoma completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease [Phase 2]
This Phase 2 trial evaluated gemcitabine-based chemotherapy followed by peripheral blood stem cell rescue for Hodgkin lymphoma. Results were…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study evaluating plerixafor (AMD3100) as a stem cell mobilizer for transplantation from a sibling donor in various hematologic mal…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT [Phase 2]
Phase 2 trial of sirolimus and mycophenolate mofetil as graft-versus-host disease prophylaxis in myeloablative, matched related donor hemato…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy and radiation therapy in young patients with newly diagnosed Hodgkin Lymphoma; results pos…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen with alemtuzumab, fludarabine phosphate, and total-body irradiation followed by cyclosporine…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating bendamustine hydrochloride, rituximab, etoposide, and carboplatin in relapsed/refractory diffuse large B-cell lym…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma [Phase 1, Phase 2]
Clinical trial investigating Yttrium-90-labeled daclizumab with chemotherapy and stem cell transplant in Hodgkin lymphoma has terminated; re…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma [Phase 2]
Phase 2 study evaluating the combination of bendamustine hydrochloride, etoposide, dexamethasone, and filgrastim for peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating cyclophosphamide as GVHD prophylaxis after allogeneic peripheral blood stem cell transplantation in patients with h…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial
Biomarker analyses in tissue samples from patients with Hodgkin lymphoma enrolled in the ECOG-ACRIN ECOG-2496 trial; the study has completed…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma [Phase 1, Phase 2]
A pediatric Phase 1/2 study of brentuximab vedotin (ADCETRIS) in relapsed or refractory systemic anaplastic large cell lymphoma or Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan, melphalan, and thiotepa for patients undergoing autologous stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma [Phase 4]
Phase 4 clinical trial update for brentuximab vedotin in relapsed or refractory Hodgkin lymphoma, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating pentostatin and lymphocyte infusion to prevent graft rejection after donor stem cell transplantation—compl…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors [Phase 2]
Phase 2 clinical trial evaluating the combination of plerixafor and GM-CSF (sargramostim) for mobilizing hematopoietic stem cells from allog…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma [Phase 2]
Phase 2 trial assessing Avastin (bevacizumab) added to ABVD chemotherapy for advanced-stage Hodgkin lymphoma was terminated. Results have be…